Objectives We examined the incidence trends of bladder and kidney cancers using a population-based cancer registration data. Methods Age-standardized incidence rates were analyzed using data from the Shanghai Cancer Registry during 1973 to 2005. Annual percentage changes and 95% confidence intervals were calculated to evaluate the incidence changes. Age-period-cohort analysis was further implemented to assess the contributions of age, period and cohort effects to the trends using the intrinsic estimator method. Results In total, 12,676 bladder and 5,811 kidney cancer patients were registered in urban Shanghai. The age-standardized rates of bladder cancer in males increased from 6.39 to 7.66 per 100,000, or 0.62% per year, whereas the rates in females increased from 1.95 to 2.09 per 100,000, or 0.33% per year. For kidney cancer, the age-standardized rates in males increased from 1.20 to 5.64 per 100,000, or 6.98% per year. Similarly in females, the rates increased from 0.85 to 3.33 per 100,000, or 5.93% per year. Age-period-cohort analysis showed increasing curves of age and period effects but generally decreasing cohort effects for bladder and kidney cancers. Conclusions Our results show increasing incidence trends of bladder and kidney cancers in Chinese men and women, especially for kidney cancer.
References
[1]
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. . Lyon, France: ？International Agency for Research on Cancer ; 2010. Available: . http://globocan.iarc.fr , Accessed 10 October 2012.
[2]
Sun M, Thuret R, Abdollah F, Lughezzani G et al. (2011) Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 59: 135-141. doi:10.1016/j.eururo.2010.10.029. PubMed: 21035250.
[3]
Ondrusova M, Ondrus D, Muzik J, Hunakova L, Hes O et al. (2011) Trends in the kidney cancer incidence and mortality in the Slovak and Czech Republics in 1980-2005 - in the context of an international comparison. Neoplasma 58: 165-171. doi:10.4149/neo_2011_02_165. PubMed: 21288054.
[4]
Zheng T, Holford TR, Chen Y, Ma JZ, Mayne ST et al. (1996) Time trend and age-period-cohort effect on incidence of bladder cancer in Connecticut, 1935-1992. Int J Cancer 68: 172-176. doi:10.1002/(SICI)1097-0215(19961009)68:2. PubMed: 8900423.
[5]
Kiemeney LA, Coebergh JW, Koper NP, van der Heijden LH, Pauwels RP et al. (1994) Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A: 1134-1137. PubMed: 7654445.
[6]
Gao YT, Lu W (2007) Cancer Incidence, Mortality and Survival Rates in Urban Shanghai (1973-2000). Shanghai, China: Second Military Medical University Press.
[7]
Gao S, Yang WS, Bray F, Va P, Zhang W et al. (2012) Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Eur J Epidemiol 27: 39-46. doi:10.1007/s10654-011-9636-8. PubMed: 22160277.
[8]
Wu QJ, Vogtmann E, Zhang W, Xie L, Yang WS et al. (2010) Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005. PLOS ONE 7: e42607.
[9]
Bray F, Parkin DM (2009) Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45: 747-755. doi:10.1016/j.ejca.2008.11.032. PubMed: 19117750.
[10]
Doll R, Payne P, Waterhouse J, eds. (1966) Cancer Incidence in Five Continents: a Technical Report. Berlin: Springer-Verlag (for UICC).
[11]
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation test for joinpoint regression with applications to cancer rates. Statist. Med. 19: 335-51 (correction: 2001; 20: 655).
[12]
Kleinbaum Kupper, Muller (1988) Applied Regression Analysis and Other Multivariable Methods. PWS-Kent, Boston, Mass., 2nd edition.
[13]
Yang Y, Fu W, Land KC (2004) A methodological comparison of age-period-cohort models: The intrinsic estimator and conventional generalized linear models. Sociol Methodol 34: 75-110. doi:10.1111/j.0081-1750.2004.00148.x.
[14]
Yang Y, Schulhofer-Wohl S, Fu W, Land KC (2008) The intrinsic estimator for age-period-cohort analysis: What it is and how to use it. Am J Sociol 113: 1697-1736. doi:10.1086/587154.
[15]
Fu W, Land KC, Yang Y (2011) On the intrinsic estimator and constrained estimators in age-period-cohort models. Sociol Methods Res 40: 453-466. doi:10.1177/0049124111415355.
[16]
Holford TR (1983) The estimation of age, period and cohort effects for vital rates. Biometrics 39: 311-324. doi:10.2307/2531004. PubMed: 6626659.
[17]
Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12: 425-457. doi:10.1146/annurev.pu.12.050191.002233. PubMed: 2049144.
[18]
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N et al. (2013) SEER Cancer Statistics Review. National Cancer Institute. Bethesda, MD. pp. 1975-2010 Available:？. http://seer.cancer.gov/csr/1975_2010/. Accessed 16 July 2013.
[19]
Mathew A, Devesa SS, Fraumeni JF, Chow WH (2002) Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11: 171-178. doi:10.1097/00008469-200204000-00010. PubMed: 11984136.
[20]
Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat. Rev Urol 7: 245-257. doi:10.1038/nrurol.2010.46.
[21]
Tarone RE, Chu KC, Gaudette LA (1997) Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada. J Natl Cancer Inst 89: 251-256. doi:10.1093/jnci/89.3.251. PubMed: 9017006.
[22]
Barentsz JO, Ruijs SH, Strijk SP (1993) The role of MR imaging in carcinoma of the urinary bladder. AJR Am J Roentgenol 160: 937-947. doi:10.2214/ajr.160.5.8470608. PubMed: 8470608.
[23]
Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C (1995) Prognostic significance of incidental renal cell carcinoma. Eur Urol 27: 319-323. PubMed: 7656910.
[24]
Frost WH (1995) The age selection of mortality from tuberculosis in successive decades, 1939. Am J Epidemiol 141: 4-9. PubMed: 7801964.
[25]
Scélo G, Brennan P (2007) The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 4: 205-217. doi:10.1038/ncpuro0760. PubMed: 17415353.
[26]
Zhang J, Ou JX, Bai CX (2011) Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology 16: 1165-1172. doi:10.1111/j.1440-1843.2011.02062.x. PubMed: 21910781.
[27]
Yang G, Fan L, Tan J, Qi G, Zhang Y et al. (1999) Smoking in China: findings of the 1996 National Prevalence Survey. JAMA 282: 1247-1253. doi:10.1001/jama.282.13.1247. PubMed: 10517427.
[28]
Yang GH, Ma JM, Liu N, Zhou LN (2005) Smoking and passive smoking in Chinese, 2002.Zhonghua Liu Xing Bing Xue Za Zhi 26: 77-83.
[29]
Tao L, Xiang YB, Wang R, Nelson HH, Gao YT et al. (2010) Environmental tobacco smoke in relation to bladder cancer risk--the Shanghai bladder cancer study [corrected]. Cancer Epidemiol Biomarkers Prev 19: 3087-3095. doi:10.1158/1055-9965.EPI-10-0823. PubMed: 21056942.
[30]
Leiba A, Kark JD, Afek A, Levi Z, Barchana M et al. (2012) Overweight in adolescence is related to increased risk of future urothelial cancer. Obesity (Silver Spring) 20: 2445-2450. doi:10.1038/oby.2012.83. PubMed: 22510956.
[31]
Gray L, Lee IM, Sesso HD, Batty GD (2012) Association of body mass index in early adulthood and middle age with future site-specific cancer mortality: the Harvard Alumni Health Study. Ann Oncol 23: 754-759. doi:10.1093/annonc/mdr270. PubMed: 21677311.
[32]
Tavani A, Zucchetto A, Dal Maso L, Montella M, Ramazzotti V et al. (2007) Lifetime physical activity and the risk of renal cell cancer. Int J Cancer 120: 1977-1980. doi:10.1002/ijc.22438. PubMed: 17266025.
[33]
Hock LM, Lynch J, Balaji KC (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: An analysis of surveillance, epidemiology, and end results program data. J Urol 167: 57-60. doi:10.1016/S0022-5347(05)65382-7. PubMed: 11743275.
[34]
Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, et al. (2007) SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD. pp. 193-202.
[35]
Liu L, Ikeda K, Chen M, Yin W, Mizushima S et al. (2004) Obesity, emerging risk in China: trend of increasing prevalence of obesity and its association with hypertension and hypercholesterolaemia among the Chinese. Clin Exp Pharmacol Physiol 31 Suppl 2: S8-10. doi:10.1111/j.1440-1681.2004.03954.x. PubMed: 15649295.
[36]
Song Y, Wang HJ, Ma J, Wang Z (2013) Secular trends of obesity prevalence in urban Chinese children from 1985 to 2010: gender disparity. PLOS ONE 8: e53069. doi:10.1371/journal.pone.0053069. PubMed: 23308137.
